Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
| Previous close | 65.28 |
| Open | 65.00 |
| Bid | 65.91 x 200 |
| Ask | 66.23 x 200 |
| Day's range | 64.62 - 66.25 |
| 52-week range | 25.98 - 110.25 |
| Volume | |
| Avg. volume | 1,930,713 |
| Market cap | 6.909B |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
On May 7, 2024, Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 15,547 shares of the company.
- Zacks
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics Inc (NASDAQ:CYTK), a biopharmaceutical company focused on the discovery and development of next-generation therapeutics for muscle diseases, has reported an insider sale according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.